Varespladib methyl + varespladib for snake bites

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Feb 2023: Trial registered, NCT05717062
  2. 30 May 2023: Trial started, NCT05717062

The trials

NCT05717062: Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)

State
Completed
Phase
Phase 2
People
140 taking part
Started
30 May 2023
Primary completion
28 Nov 2024
Arms
Varespladib Intravenous Form (IV) + Varespladib Oral tablet (LY315920) + SOC
Results
None posted
  1. 8 Feb 2023: Trial registered
  2. 30 May 2023: Trial started
  3. 24 Feb 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.